This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Plaintiffs win class certification in US antitrust case over Tracleer

( September 6, 2024, 19:24 GMT | Official Statement) -- MLex Summary: An employee health fund won class certification in a US case against Actelion Pharmaceuticals over delayed entry of a generic version of its hypertension drug Tracleer. The proposed class includes entities that purchased, paid and/or provided reimbursement for some or all of the purchase price of Tracleer or bosentan in the class states and territories at any time from December 2015 through and until the anticompetitive effects of the challenged conduct cease.See document below. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections